Beam therapeutics presents new non-human primate (nhp) data demonstrating proof-of-concept for escape, a non-genotoxic, antibody-based conditioning approach to treating sickle cell disease, at american society of hematology (ash) annual meeting

Nhp data showed cd117 monoclonal antibody (mab) conditioning successfully achieved long-term engraftment of base-edited hematopoietic stem cells and induced robust levels of hemoglobin f

ASH Ratings Summary

ASH Quant Ranking